University of California, San Francisco psychedelic research trials
Data as of 11 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.
University of California, San Francisco is listed with 14 registered studies counted here, in San Francisco, United States. By compound: 12 psilocybin and 2 ketamine. By registry status: 4 recruiting, 1 not yet recruiting, 2 enrolling by invitation, 3 active, not recruiting, 2 completed, 1 terminated and 1 status not reported. By phase: 6 phase 1, 7 phase 2 and 1 phase 4. Reported start years run from 2018 (earliest) to 2026 (latest).
Institution name, city and country are copied from the research site linked to each registry record. A study counts once per institution, and a study tagged with more than one compound is counted under each compound.
Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.
At a glance
- 14 registered studies are counted on this page.
By compound
| Compound hub | Studies |
|---|---|
| Psilocybin | 12 |
| Ketamine | 2 |
By registry status
| Status | Studies | Share |
|---|---|---|
| Recruiting | 4 | 29% |
| Not yet recruiting | 1 | 7% |
| Enrolling by invitation | 2 | 14% |
| Active, not recruiting | 3 | 21% |
| Completed | 2 | 14% |
| Terminated | 1 | 7% |
| Status not reported | 1 | 7% |
By phase
| Phase | Studies | Share |
|---|---|---|
| Phase 1 | 6 | 43% |
| Phase 2 | 7 | 50% |
| Phase 4 | 1 | 7% |
Registered studies
All counted studies, newest start first. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.
| Title as registered | Registry ID | Status | Phase | Start | Compound |
|---|---|---|---|---|---|
| Psilocybin Therapy for Methamphetamine Use Disorder and HIV | NCT07756736 | Not yet recruiting | Phase 2 | 2026-11-01 | Psilocybin |
| A Study of Psychedelics in Healthy Older Adults With Low Well-being | NCT07386730 | Recruiting | Phase 1 | 2026-03-01 | Psilocybin |
| Ketamine Effects on Learning In Eating Disorders | NCT06736769 | Enrolling by invitation | Phase 2 | 2025-06-05 | Ketamine |
| Psilocybin With Intracranial Neural Sensing | NCT06919640 | Enrolling by invitation | Phase 1 | 2025-06-01 | Psilocybin |
| Study of Psilocybin for Anorexia in Young Adults | NCT06399263 | Recruiting | Phase 2 | 2024-11-18 | Psilocybin |
| Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers | NCT06626139 | Recruiting | Phase 2 | 2024-10-20 | Psilocybin |
| Psilocybin Therapy for Depression in Parkinson's Disease | NCT06455293 | Recruiting | Phase 2 | 2024-08-19 | Psilocybin |
| Ketamine-assisted Therapy for Advanced GI Cancer | NCT06077487 | Terminated | Phase 4 | 2024-05-17 | Ketamine |
| Psilocybin Therapy for Chronic Low Back Pain | NCT05351541 | Active, not recruiting | Phase 1 | 2023-12-01 | Psilocybin |
| Neural and Physiological Correlates of Psychedelic Sub-states | NCT05698511 | Active, not recruiting | Phase 1 | 2023-07-31 | Psilocybin |
| Comparing the Effects of Psilocin and Psilocybin in Healthy Adults | NCT05317689 | Status not reported | Phase 1 | 2022-05-26 | Psilocybin |
| Psilocybin Therapy for Depression in Bipolar II Disorder | NCT05065294 | Active, not recruiting | Phase 2 | 2022-01-28 | Psilocybin |
| Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease | NCT04932434 | Completed | Phase 2 | 2021-08-15 | Psilocybin |
| Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors | NCT02950467 | Completed | Phase 1 | 2018-01-05 | Psilocybin |
About this data
Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.